FGF‐21 and GDF‐15 levels were elevated at baseline and increased further at 6 then 12 weeks with increased dose (Figs 2A and EV2) irrespective of gender, body mass index, body surface area or diabetes mellitus (Fig EV3). Here, FGF21 is linked to diabetes mellitus.